z-logo
Premium
Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib
Author(s) -
Tomuleasa Ciprian,
Giannelli Gianluigi,
Cucuianu Andrei,
Aldea Mihaela,
Paradiso Angelo,
BerindanNeagoe Ioana
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.26907
Subject(s) - sorafenib , tumor microenvironment , cancer research , cancer cell , cancer , metastasis , stromal cell , medicine , immunology , immune system , hepatocellular carcinoma

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here